Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Laura Murillo Sanjuán

Laura Murillo Sanjuán

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Laura Murillo Sanjuán

Laura Murillo Sanjuán

Laura Murillo Sanjuán

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders

IP: Lucas Moreno Martín-Retortillo
Collaborators: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, Maria Luz Uría Oficialdegui, Maria Jose Pérez García, Miguel Segura Ginard, M Mar Mañu Pereira, Lorena Valero Arrese, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Raquel Hladun Alvaro, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Gabriela Guillén Burrieza, Laura Alonso Garcia, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Elena Andretta, Claire Diot, Amira Idrizovic
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00638
Duration: 01/01/2022 - 30/06/2025

Related news

Hospital infantil i de la dona

Hope4Kids to promote more equitable and integrated paediatric palliative care in Europe

The European initiative Hope4Kids will strengthen and harmonise paediatric palliative care across Europe, with the aim of ensuring comprehensive, high-quality care for all children living with life-threatening or life-limiting conditions.

KIDS Vall d'Hebron

Vall d'Hebron creates the KIDS group to promote children's participation in research

The initiative will enable young people aged 12 to 18 to collaborate with campus researchers in the design, development and communication of scientific projects, placing patients and families at the centre of the research process.

Equip de l'estudi

A study shows the long-term benefits of ruxolitinib in paediatric GVHD

The REACH5 study confirms that the efficacy and safety results observed in previous studies are maintained after three years of follow-up.

See more

Related professionals

Meri Montero Cueto

Meri Montero Cueto

Gestió i Administració
Accounting and Revenue Unit
Finance Directorate
Read more
Clara Serra Marrugat

Clara Serra Marrugat

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Fernando Lozano Palacio

Fernando Lozano Palacio

Postdoctoral researcher
Biomedical Research in Urology
Read more
Jose Piedra Miravet

Jose Piedra Miravet

Research assistant
Gene Therapy at Nervous System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.